JP2003043031A - Blood filtering unit - Google Patents

Blood filtering unit

Info

Publication number
JP2003043031A
JP2003043031A JP2001232121A JP2001232121A JP2003043031A JP 2003043031 A JP2003043031 A JP 2003043031A JP 2001232121 A JP2001232121 A JP 2001232121A JP 2001232121 A JP2001232121 A JP 2001232121A JP 2003043031 A JP2003043031 A JP 2003043031A
Authority
JP
Japan
Prior art keywords
glass fiber
filter paper
fiber filter
plasma
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001232121A
Other languages
Japanese (ja)
Inventor
Toshifuru Ito
敏古 伊藤
Hideaki Kosha
秀明 古謝
Yuji Mihara
祐治 三原
Kikuo Hirai
希久生 平井
Kaoru Terajima
薫 寺島
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujifilm Holdings Corp
Original Assignee
Fuji Photo Film Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuji Photo Film Co Ltd filed Critical Fuji Photo Film Co Ltd
Priority to JP2001232121A priority Critical patent/JP2003043031A/en
Publication of JP2003043031A publication Critical patent/JP2003043031A/en
Pending legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To provide a blood filtering unit capable of separating plasma or serum from a small amount of whole blood efficiently. SOLUTION: In the blood filtering unit, glass fiber-filter paper is filled into a vessel that has at least two openings and has a diameter of approximately 1 cm or less so that the ratio of length/diameter is 1/2 or more.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明は、ガラス繊維濾紙を
主な濾材として全血から血漿又は血清を濾過する血液濾
過ユニットに関する。更に詳しくは、本発明は、少量の
全血試料から効率よく血漿又は血清(以下、「血漿等」
と記す)を分離できる血液濾過ユニットに関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a hemofiltration unit for filtering plasma or serum from whole blood using glass fiber filter paper as a main filter material. More specifically, the present invention provides efficient plasma or serum (hereinafter, “plasma etc.”) from a small amount of whole blood sample.
A) is separated.

【0002】[0002]

【従来の技術】血液中の構成成分例えば代謝産物、蛋白
質、脂質、電解質、酵素、抗原、抗体などの種類や濃度
の測定は血漿等を検体として行われている。全血から血
漿等を分離する方法としては、遠心分離法と濾過法が知
られているが、遠心分離は手間と時間がかかる。特に少
数の検体を急いで処理したいときや、現場検査などに
は、電気を動力とし、遠心分離機を必要とする遠心法は
不向きであり、濾過法の方が好ましい。
2. Description of the Related Art The types and concentrations of constituents in blood such as metabolites, proteins, lipids, electrolytes, enzymes, antigens and antibodies are measured using plasma or the like as a sample. Centrifugation and filtration are known as methods for separating plasma and the like from whole blood, but centrifugation takes time and effort. Especially when a small number of specimens are to be processed promptly or in the field, etc., the centrifugal method using electricity as a power source and requiring a centrifugal separator is not suitable, and the filtration method is preferable.

【0003】この濾過方法には、ガラス繊維濾紙をカラ
ムに充填し、カラムの一方から全血を注入し、加圧や減
圧を行なって他方から血漿等を得るいくつかの方法が公
知化されている(特公昭44−14673号公報、特開
平2−208565号公報、特開平4−208856号
公報、特公平5−52463号公報等)。
For this filtration method, several methods have been publicly known, in which a column is filled with glass fiber filter paper, whole blood is injected from one side of the column, and pressure or pressure is applied to obtain plasma or the like from the other side. (JP-B-44-14673, JP-A-2-208565, JP-A-4-208856, JP-B-5-52463, etc.).

【0004】更に、本出願人は、血漿等を効率よく分離
しうる血液濾過ユニットとして、濾材にガラス繊維濾紙
と微多孔性膜を組み合わせるとともに濾材の血漿出口側
にシール部材を設けて濾過材料の開口面積を狭めた血液
濾過ユニット等について出願した(特開平9−1969
11号公報等)。
Furthermore, the applicant of the present invention, as a blood filtration unit capable of efficiently separating plasma and the like, combines a filter material with glass fiber filter paper and a microporous membrane and provides a sealing member on the plasma outlet side of the filter material to provide a filter material. An application was filed for a blood filtration unit having a narrow opening area (Japanese Patent Laid-Open No. 9-1969).
No. 11, etc.).

【0005】本出願人はこれらの発明に基づいて血液濾
過ユニットを完成し、富士ドライケムプラズマフィルタ
ーなる商品名で市販している。この血液濾過ユニットに
より、乾式分析素子(例えば、富士写真フイルム製の富
士ドライケム)を用いて、自動分析装置によって多くの
項目を分析するのに必要な量の血漿等を簡便に得ること
ができる。
The present applicant has completed a blood filtration unit based on these inventions and is commercially available under the trade name of Fuji Dry Chem Plasma Filter. With this blood filtration unit, it is possible to easily obtain the amount of plasma or the like required for analyzing many items by an automatic analyzer by using a dry analysis element (for example, Fuji Drychem manufactured by Fuji Photo Film).

【0006】しかし、上記血液濾過ユニットは、ユニッ
トのデッドボリュームの部分を除いても、全血から血漿
等を分離する効率が十分に高いとはいえず、所定量の血
漿等を得るためには、相当量の全血を必要としている。
多くの場合健康状態が良好とはいえない被検者、特に幼
児や高年齢者の負担を軽減するためには、採血量は少な
い方が好ましく、約1ml以下に留めるのが好ましい。
このためには、全血から血漿等を更に効率よく分離する
技術が望まれている。
However, the above-mentioned hemofiltration unit cannot be said to have a sufficiently high efficiency of separating plasma or the like from whole blood even if the dead volume part of the unit is removed. , Need a significant amount of whole blood.
In many cases, in order to reduce the burden on subjects whose health condition is not good, especially infants and elderly people, it is preferable that the blood collection amount is small, and it is preferable to keep the blood collection amount to about 1 ml or less.
For this purpose, a technique for more efficiently separating plasma or the like from whole blood is desired.

【0007】従来、ガラス繊維濾紙を用いて全血から血
漿等を分離する場合に、ガラス繊維濾紙はいわゆる体積
濾過材料として機能すると考えられていた(例えば、特
開昭61−038608号公報)。即ち、ガラス繊維濾
紙の表面ではなくて、ガラス繊維の内部に形成される空
隙によって、血液中の大きな成分(例えば白血球や赤血
球)が比較的初期に捉えられ、血漿等のような液体成分
はその間隙を縫って流動して全血から分離されると考え
られていた。このため、濾過される血漿等の量を増やす
にはガラス繊維濾紙の全体積を増やす方が有利と考えら
れるが、この場合にはガラス繊維濾紙の内部に残留する
血漿等も増えるため、濾過される血漿の量が希望通りに
は増えないという問題があった。
Conventionally, when separating plasma or the like from whole blood using a glass fiber filter paper, it has been considered that the glass fiber filter paper functions as a so-called volumetric filtration material (for example, Japanese Patent Laid-Open No. 61-038608). That is, large components (for example, white blood cells and red blood cells) in blood are captured relatively early by the voids formed inside the glass fiber, not on the surface of the glass fiber filter paper, and liquid components such as plasma are It was thought to sew through the gap and flow away to be separated from whole blood. Therefore, it is considered to be advantageous to increase the total volume of the glass fiber filter paper in order to increase the amount of plasma or the like to be filtered, but in this case, the plasma etc. remaining inside the glass fiber filter paper also increases, so There was a problem that the amount of blood plasma was not increased as desired.

【0008】[0008]

【発明が解決しようとする課題】本発明の目的は、ガラ
ス繊維濾紙を主な濾過材料として使用し、少量の全血、
特に約1ml以下の全血から血漿等を効率よく分離する
血液濾過ユニットを提供することにある。
The object of the present invention is to use glass fiber filter paper as the main filtering material,
Particularly, it is to provide a hemofiltration unit that efficiently separates plasma and the like from about 1 ml or less of whole blood.

【0009】[0009]

【課題を解決するための手段】本発明者らは上記課題を
解決すべく、全血からの血漿等の分離機構に着目し、そ
の解明を図った。その結果、驚くべきことに、赤血球は
ガラス繊維濾紙の空隙に捉えられるのではなく、ガラス
繊維に、特に直径が約2μm以下のガラス繊維に一時的
に巻き付き、このために血漿等と較べてガラス繊維濾紙
内部の移動速度に差が出ていることが判った。即ち、ガ
ラス繊維濾紙を用いた血液濾過において、血漿等は体積
濾過によって分離されているのではなく、液体クロマト
グラフィー的機構によって分離されていることが判っ
た。図1に、ガラス繊維濾紙中の細いガラス繊維に赤血
球が巻き付いている状況を示す。
[Means for Solving the Problems] In order to solve the above-mentioned problems, the present inventors focused on the mechanism of separating plasma and the like from whole blood and clarified it. As a result, surprisingly, the red blood cells are not caught in the voids of the glass fiber filter paper, but are temporarily wrapped around the glass fibers, especially the glass fibers having a diameter of about 2 μm or less, which makes the glass cells more viscous than plasma and the like. It was found that there was a difference in the moving speed inside the fiber filter paper. That is, in blood filtration using glass fiber filter paper, it was found that plasma and the like were not separated by volumetric filtration but by a liquid chromatographic mechanism. FIG. 1 shows a situation in which red blood cells are wrapped around the thin glass fibers in the glass fiber filter paper.

【0010】本発明は、分離機構に関するこのような知
見に基づいてなされたものであり、平均直径が約2μm
以下のガラス繊維を約10%〜約90%含むガラス繊維
濾紙を主な濾過材料として使用し、その形状を選択する
ことにより分離効率の良い血液濾過ユニットを完成する
ことができた。
The present invention has been made on the basis of such knowledge regarding the separation mechanism, and has an average diameter of about 2 μm.
A glass fiber filter paper containing about 10% to about 90% of the following glass fibers was used as a main filtering material, and the shape thereof was selected, whereby a hemofiltration unit with good separation efficiency could be completed.

【0011】すなわち、本発明は、濾材の主体として平
均直径が約2μm以下のガラス繊維を約10%〜約90
%含むガラス繊維濾紙を用い、直径が約10mm以下
で、かつ長さ/直径が約1/2以上であることを特徴と
する血液濾過ユニットに関するものである。
That is, in the present invention, glass fibers having an average diameter of about 2 μm or less are used as the main component of the filter medium in an amount of about 10% to about 90%.
%, And a length / diameter of about ½ or more and a diameter of about 10 mm or less.

【0012】[0012]

【発明の実施の形態】上記のように液体クロマトグラフ
ィー的機構によって分離されるのであれば、流路を長く
とる方が分離効率がよくなると考えられる。しかし、ガ
ラス繊維濾紙の全体の体積が大きくなると、少量の全
血、特に約1ml程度以下の全血を濾過することが困難
あるいは不可能になる。このため、ガラス繊維濾紙の断
面積を一定値以下にし、かつガラス繊維濾紙の断面積に
対する流路の長さ(ガラス繊維濾紙の厚さ)を一定値以
上にすることが好ましい。この値は、実験的に定めるこ
とができる。例えば、GF/D(ワットマン社製ガラス
繊維濾紙)を用いた場合には、円の場合は直径約1cm
以下(あるいは断面積が約0.79cm2以下)で、長
さ/直径の比が1/2以上であることが好ましく、円の
場合は直径約0.8cm以下(あるいは断面積が約0.
50cm2以下)で、長さ/直径の比が約1.2/2以
上であることが更に好ましい。必要な長さの流路を得る
には、ガラス繊維濾紙を複数枚重ねることが好ましい
が、ガラス繊維濾紙をロール状に巻いて使用することも
できる。
BEST MODE FOR CARRYING OUT THE INVENTION If separation is carried out by a liquid chromatographic mechanism as described above, it is considered that the separation efficiency will be improved by making the channel longer. However, if the entire volume of the glass fiber filter paper becomes large, it becomes difficult or impossible to filter a small amount of whole blood, especially about 1 ml or less of whole blood. Therefore, it is preferable that the cross-sectional area of the glass fiber filter paper is set to a certain value or less, and the length of the flow path (the thickness of the glass fiber filter paper) to the cross-sectional area of the glass fiber filter paper is set to a certain value or more. This value can be determined experimentally. For example, when GF / D (glass fiber filter paper manufactured by Whatman) is used, in the case of a circle, the diameter is about 1 cm.
It is preferable that the length is less than or equal to (or the cross-sectional area is about 0.79 cm 2 or less) and the length / diameter ratio is equal to or more than 1/2. In the case of a circle, the diameter is about 0.8 cm or less (or the cross-sectional area is about 0.
It is further preferred that the length / diameter ratio is about 1.2 / 2 or more at 50 cm 2 or less). In order to obtain a flow path having a required length, it is preferable to stack a plurality of glass fiber filter papers, but it is also possible to wind the glass fiber filter papers in a roll shape for use.

【0013】この場合に、約1mlの全血検体を処理す
るのに適したガラス繊維濾紙の全体積は、1100mm
3である。これを超えると濾紙中にとどまる血漿等の量
が増えるので、好ましくない。検体の量がこれより少な
い場合には、ガラス繊維濾紙の好ましい全体積は検体の
量に比例して減少する。
In this case, the total volume of glass fiber filter paper suitable for processing about 1 ml of whole blood sample is 1100 mm.
Is 3 . If it exceeds this, the amount of plasma and the like remaining in the filter paper increases, which is not preferable. For smaller amounts of analyte, the preferred total volume of glass fiber filter paper decreases in proportion to the amount of analyte.

【0014】ガラス繊維濾紙は、通常、平均直径の異な
る2種のガラス繊維群で構成されている。上記GF/D
では平均直径が約2μm以下のガラス繊維が約55%含
まれている。ガラス繊維濾紙は抄紙法により製造される
ので、ガラス繊維濾紙の内部において、太さの異なるガ
ラス繊維の分布を制御することはできず、相互に均一に
分布しているものと解される。
The glass fiber filter paper is usually composed of two kinds of glass fiber groups having different average diameters. GF / D above
Contains about 55% of glass fibers having an average diameter of about 2 μm or less. Since the glass fiber filter paper is produced by a papermaking method, it is understood that the distribution of glass fibers having different thicknesses cannot be controlled inside the glass fiber filter paper and they are uniformly distributed.

【0015】ガラス繊維濾紙の密度は0.02〜0.5
g/cm3程度、好ましくは0.03〜0.2g/cm3
程度、特に好ましくは0.05〜0.13g/cm3
度で、保留粒子径が0.6〜9μm程度、特に1〜5μ
m程度のものが好ましい。
The density of the glass fiber filter paper is 0.02 to 0.5.
g / cm 3 or so, preferably 0.03 to 0.2 g / cm 3
Degree, particularly preferably about 0.05 to 0.13 g / cm 3 , and the retained particle size is about 0.6 to 9 μm, particularly 1 to 5 μm.
It is preferably about m.

【0016】このようなガラス繊維濾紙を用いて血液濾
過ユニットを作成するには、ガラス繊維濾紙を一定形状
の容器内に収納することが好ましい。この容器は、全血
の吸引用及び濾過された血漿等の取り出し用の、少なく
とも2個の開口を有していればよい。ガラス繊維濾紙の
断面形状に制約は無く、円形、方形、六角形等の任意の
形状でよいが、製造の容易さからは円形が好ましく、ガ
ラス繊維濾紙の廃棄部分を出さない点では方形が好まし
い。
In order to prepare a blood filtration unit using such a glass fiber filter paper, it is preferable to store the glass fiber filter paper in a container having a fixed shape. This container may have at least two openings for sucking whole blood and taking out filtered plasma or the like. There is no restriction on the cross-sectional shape of the glass fiber filter paper, and it may be any shape such as circular, rectangular, hexagonal, etc. However, circular shape is preferable from the viewpoint of ease of manufacturing, and rectangular shape is preferable from the point of not discarding the waste part of the glass fiber filter paper .

【0017】ガラス繊維濾紙の濾過血漿の出口側には、
表面が親水性の微多孔性膜を設置して、ガラス繊維濾紙
を通過して表面に出てくる赤血球を捕獲することが好ま
しい。この微多孔性膜は孔径がガラス繊維濾紙の保留粒
子径より小さくかつ0.2μm以上、好ましくは0.3
〜5μm程度、より好ましくは0.5〜3μm程度のも
のが適当である。また、空隙率は高いものが好ましく、
具体的には、空隙率が約40%から約95%、好ましく
は約50%から約95%、さらに好ましくは約70%か
ら約95%の範囲のものが適当である。微多孔性膜の例
としてはポリスルホン膜、弗素含有ポリマー膜、酢酸セ
ルローズ膜等があり、ポリスルホン膜が好ましい。微多
孔性膜の厚さは0.05〜0.5mm程度、特に0.1
〜0.3mm程度でよく、通常は1枚の微多孔性膜を用
いればよい。しかしながら、必要により複数枚を用いる
こともできる。
On the outlet side of the filtered plasma of the glass fiber filter paper,
It is preferable to install a microporous membrane having a hydrophilic surface to capture the red blood cells that pass through the glass fiber filter paper and come out to the surface. This microporous membrane has a pore size smaller than the retained particle size of the glass fiber filter paper and 0.2 μm or more, preferably 0.3.
Approximately about 5 μm, more preferably about 0.5 to 3 μm. Further, it is preferable that the porosity is high,
Specifically, a porosity of about 40% to about 95%, preferably about 50% to about 95%, more preferably about 70% to about 95% is suitable. Examples of microporous membranes include polysulfone membranes, fluorine-containing polymer membranes, cellulose acetate membranes and the like, with polysulfone membranes being preferred. The thickness of the microporous membrane is about 0.05 to 0.5 mm, especially 0.1.
It may be about 0.3 mm, and usually one microporous membrane may be used. However, a plurality of sheets can be used if necessary.

【0018】以下、実施例により本発明をより詳細に説
明するが、本発明はこれらに限定されるものではない。
Hereinafter, the present invention will be described in more detail with reference to Examples, but the present invention is not limited thereto.

【0019】[0019]

【実施例】実施例1 内径が各3.5mm、4.5mm、7.5mm、11.
5mm及び14.5mmのガラス管を用意し、この中
に、GF/D(ワットマン社製のガラス繊維濾紙)を、
濾紙の全体積が相互に近くなるように充填した。このガ
ラス管の先端を、健康な男性から採取した全血(Hct
値45%)約1.1ml中に挿入して、ペリスタポンプ
を使用して吸引した。この際、ガラス繊維濾紙内の液体
の移動速度がほぼ同一となるように、ペリスタポンプの
目盛を調整した。
EXAMPLES Example 1 Inner diameters of 3.5 mm, 4.5 mm, 7.5 mm and 11.
Glass tubes of 5 mm and 14.5 mm were prepared, and GF / D (glass fiber filter paper manufactured by Whatman) was placed in the glass tubes.
The filter papers were packed so that the total volume was close to each other. At the tip of this glass tube, whole blood (Hct
45% value) was inserted into about 1.1 ml and aspirated using a peristaltic pump. At this time, the scale of the peristaltic pump was adjusted so that the moving speed of the liquid in the glass fiber filter paper was almost the same.

【0020】試料全血の全部が各ガラス管の下端部に吸
い込まれる直前で吸引を終了した。この時にガラス繊維
濾紙の上端に溜まっている濾過された血漿の上端と下端
の位置を、マイクロCCDカメラを取り付けたビデオで
撮影した。観察倍率は、約1.2倍〜1.5倍の間であ
った。撮影後にプリンタに出力した。この出力画像を用
いて血漿部分の長さを測り、これとガラス管の内径から
得られた血漿の体積を算出した。
Suction was terminated immediately before the whole sample blood was sucked into the lower end of each glass tube. At this time, the positions of the upper and lower ends of the filtered plasma accumulated on the upper end of the glass fiber filter paper were photographed by a video equipped with a micro CCD camera. The observation magnification was between about 1.2 times and 1.5 times. Output to the printer after shooting. The length of the plasma part was measured using this output image, and the volume of plasma obtained from this and the inner diameter of the glass tube was calculated.

【0021】実験条件及び結果を表1に示す。この結果
から、ガラス管の内径、即ちガラス繊維濾紙の直径が約
10mm以下でガラス繊維濾紙の長さ/ガラス繊維濾紙
の直径が約5/10以上の時に血漿回収率が良くなり、
少量の全血から血漿を濾過分離するのに好ましいことが
判る。
The experimental conditions and results are shown in Table 1. From this result, when the inner diameter of the glass tube, that is, the diameter of the glass fiber filter paper is about 10 mm or less and the length of the glass fiber filter paper / the diameter of the glass fiber filter paper is about 5/10 or more, the plasma recovery rate is improved,
It proves to be preferable to filter plasma from a small amount of whole blood.

【0022】[0022]

【表1】 [Table 1]

【0023】[0023]

【発明の効果】本発明の濾過ユニットにより、少量の全
血から効率よく濾過により血漿等を分離することができ
る。
INDUSTRIAL APPLICABILITY With the filtration unit of the present invention, plasma and the like can be efficiently separated from a small amount of whole blood by filtration.

【図面の簡単な説明】[Brief description of drawings]

【図1】 図1は、ガラス繊維に赤血球がからみついて
いる状態を示す電子顕微鏡写真である。図1aは×1,
000、図1bは×10,000である。
FIG. 1 is an electron micrograph showing a state in which red blood cells are entangled in glass fibers. 1a is x1,
000, FIG. 1b is x10,000.

フロントページの続き (72)発明者 三原 祐治 神奈川県南足柄市中沼210番地 富士写真 フイルム株式会社内 (72)発明者 平井 希久生 埼玉県朝霞市泉水三丁目11番46号 富士写 真フイルム株式会社内 (72)発明者 寺島 薫 埼玉県朝霞市泉水三丁目11番46号 富士写 真フイルム株式会社内 Fターム(参考) 2G045 AA01 BB05 CA25 HB02 HB05Continued front page    (72) Inventor Yuji Mihara             Fuji Photo, 210 Nakanuma, Minamiashigara City, Kanagawa Prefecture             Within Film Co., Ltd. (72) Inventor Kikuo Hirai             3-11-46 Izumi, Asaka-shi, Saitama Prefecture             Shin Film Co., Ltd. (72) Inventor Kaoru Terashima             3-11-46 Izumi, Asaka-shi, Saitama Prefecture             Shin Film Co., Ltd. F-term (reference) 2G045 AA01 BB05 CA25 HB02 HB05

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】 少なくとも2の開口を有する直径が約1
cm以下の容器に、長さ/直径が1/2以上になるよう
にガラス繊維濾紙を充填した血液濾過ユニット。
1. A diameter of about 1 having at least 2 openings.
A blood filtration unit in which a glass fiber filter paper is filled so that the length / diameter is 1/2 or more in a container of cm or less.
【請求項2】 ガラス繊維濾紙の全体積が約1100m
3以下である請求項1に記載の血液濾過ユニット。
2. The total volume of glass fiber filter paper is about 1100 m.
The hemofiltration unit according to claim 1, which has a m 3 or less.
JP2001232121A 2001-07-31 2001-07-31 Blood filtering unit Pending JP2003043031A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001232121A JP2003043031A (en) 2001-07-31 2001-07-31 Blood filtering unit

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001232121A JP2003043031A (en) 2001-07-31 2001-07-31 Blood filtering unit

Publications (1)

Publication Number Publication Date
JP2003043031A true JP2003043031A (en) 2003-02-13

Family

ID=19064090

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001232121A Pending JP2003043031A (en) 2001-07-31 2001-07-31 Blood filtering unit

Country Status (1)

Country Link
JP (1) JP2003043031A (en)

Similar Documents

Publication Publication Date Title
EP0132210B1 (en) Apparatus for plasmapheresis
EP0131529B1 (en) Apparatus for plasmapheresis
EP0085016B1 (en) Device for plasmapheresis with a semi-permeable membrane apparatus
US6659975B2 (en) Plasma collecting device
CN100503020C (en) Plasma purifying membrane and plasma purifying system
JPH09196911A (en) Blood filter unit
JP3903098B2 (en) Blood filtration method
EP0502213A1 (en) Leukocyte removal method and leukocyte removal filter system
JP7356361B2 (en) Filtration cells and methods for filtering biological samples
JP2006037339A (en) Fibrous web and method for producing the same
CN102814065A (en) Plasma separation
AU2014241115A1 (en) Plasma separation from blood using a filtration device and methods thereof
EP3524977A1 (en) Plasma separation device and plasma separation method
JP2022153539A (en) Hydrophobic filter for filtering airflow or another gas flow in medical application
JP2004361419A (en) Blood filtering unit
CN112812945A (en) Malignant pleural effusion tumor cell separation device and separation method
JP2003043031A (en) Blood filtering unit
JP2003149096A (en) Blood filter film and method therefor
JP2008279195A (en) Blood separation filter device
JP2008232876A (en) Hemocyte stop membrane, blood separation filter, blood separator, and specimen sampling container
JP2000074908A (en) Hemofilter
JPH11194126A (en) Blood filtration unit
JP2000338103A (en) Separator
US20210116337A1 (en) Liquid sample processing method and liquid sample processing apparatus
JP2005164330A (en) Hemocyte separating implement

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060124

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20061208

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20080401

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080709

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20081128